Ocular Drug Delivery Solutions

  1. Streamlining The Generic Combination Device Design Assessment Process 3/19/2025

    A new six-phase assessment process simplifies regulatory approval for generic drug-device combination products, reducing costs and timelines while maintaining safety, effectiveness, and substitutability with reference-listed drugs.

  2. Battelle: 90 Years Of Innovation 3/19/2025

    Battelle, a leading nonprofit in applied science and technology, drives innovation in national security, healthcare, environment, and education while managing research labs and advancing critical discoveries.

  3. Highly Flexible And Customizable On-Body Delivery System Platform 5/27/2025

    Learn how Vertiva™ can enable delivery of micro-precision basal doses and full-content bolus injections, resulting in a highly flexible, customizable platform suitable for a wide range of therapies.

  4. Analytical Services 5/27/2025

    As part of Stevanato Group’s commitment to R&D, our analytical testing sites focus on investigating the physico-chemical properties and interactions of primary packaging materials and drug products.

  5. BD Physioject™ Disposable Autoinjector 6/26/2025

    BD Physioject™ Disposable Autoinjector offers a proven, user-friendly platform for self-injection, enhancing patient comfort, safety, and adherence across multiple chronic disease treatments globally.

  6. Manufacturing For Oral Solid Dose Success 6/30/2025

    Adare Pharma Solutions provides end-to-end CDMO services for oral solid dose drugs, enabling efficient development, manufacturing, and packaging with advanced technologies and global scale.

  7. Medical Device Solutions Fact Sheet 7/16/2025

    Battelle provides end-to-end medical device development services, combining engineering, regulatory, and human-centric design to accelerate innovation from concept through commercialization across diverse therapeutic areas.

  8. Modified-Release Formulation Strategies 10/15/2025

    Learn what oral modified-release (MR) dosage forms can offer and why they continue to rise in popularity.

  9. Formulation Strategies For Poorly Soluble Molecules 10/15/2025

    As the number of poorly soluble compounds continues to increase in the industry development pipeline, conventional formulation strategies may not be sufficient to achieve acceptable levels of solubility in the gastrointestinal tract and hence absorption into the systemic circulation.

  10. Simplify The Journey With A Combination Product Solution 10/27/2025

    Developing combination products requires navigating complex regulations. A solution that combines packaging, delivery systems, and expert support can accelerate your path to market and reduce risk.